Alpha-Gal-based Vaccine for Chagas Disease

Alpha-Gal-based Vaccine for Chagas Disease
Inventors: Katja Michael, Igor Almeida, Nathaniel Schocker
Patent No. 10,363,319

This application describes an alpha-gal based vaccine to prevent and treat infectious diseases, especially Chagas disease cause by T. cruzi.

Certain embodiments are directed to method for synthesizing and using glycoconjugates on the immunodominant epitope Galα(1,3)Galβ(1,4)GlcNAcα (Galα3LNα).

Issue Date: 07/30/2019
Application Date: 04/27/2017
Post Date: 03/27/2019

UTEP Docket No: 2015-011